Abstract
This study aimed at identifying the potential benefits of using a patient specific aperture in proton beam scanning. For this purpose an accurate Monte Carlo model of the pencil beam scanning (PBS) proton therapy (PT) treatment head at Massachusetts General Hospital (MGH) was developed based on an existing model of the passive double-scattering (DS) system. The Monte Carlo code specifies the treatment head at MGH with sub-millimeter accuracy. The code was configured based on the results of experimental measurements performed at MGH. This model was then used to compare out-of-field doses in simulated double-scattering (DS) treatments and PBS treatments
For the conditions explored, the penumbra in PBS is wider than in DS, leading to higher absorbed doses and equivalent doses adjacent to the primary field edge. For lateral distances greater than 10cm from the field edge, the doses in PBS appear to be lower than those observed for DS.
We found that placing a patient-specific aperture at nozzle exit during PBS treatments can potentially reduce doses lateral to the primary radiation field by over an order of magnitude. In conclusion, using a patient-specific aperture has the potential to further improve the normal tissue sparing capabilities of PBS.
Keywords: proton therapy, pencil beam scanning, Monte Carlo simulation, patient-specific aperture
1. Introduction
Pencil beam scanning (PBS) proton therapy (PT) has the potential to deliver highly conformal fields with reduced dose external to the primary field compared to double scattering (DS) PT. In PBS, magnets are used to scan the proton beam laterally and the energy of the proton beam is typically altered without beam modifying devices to achieve conformality in three dimensions. In contrast to DS, PBS has the ability to conform the dose to both the proximal and distal edges of the target (Lomax et al., 2004). PBS treatments can also be delivered without patient-specific hardware, which is required to achieve conformality to the lateral and distal edges of the target in DS (Kooy et al., 2010). Not using patient-specific hardware reduces the amount of material in the path of the beam, which decreases the total number of proton interactions occurring in the treatment nozzle, leading to a lower neutron dose from PBS (Schneider et al., 2002).
There are two principle methods of beam scanning used in PT, which we define as spot scanning and continuous scanning. Spot scanning involves delivering dose in a series of finite steps. After the delivery of each spot, the beam is turned off while the elements which steer the beam are reconfigured to deliver the next spot. This reconfiguration may require a change in the beam position, energy or both depending on the individual facility and the chosen scanning methodology. The primary difference between continuous scanning and spot scanning is that during continuous scanning, the beam remains on while the position is altered. Scanning fields at MGH are delivered via a series of two-dimensional layers of constant proton energy (and hence range in water). The distal layer is irradiated first, then the energy is reduced and the subsequent layer irradiated. This process continues until the entire field has been delivered. Other PT centers may use a different scanning method, depending on the hardware properties of the given facility.
Previous work by Paganetti et al (2004) has demonstrated the ability to accurately simulate DS proton therapy treatments using the Geant4 Monte Carlo toolkit (Agostinelli et al., 2003). Modeling the DS treatment nozzle with sub-millimeter accuracy allowed the simulation of dose distributions from spread out Bragg peak (SOBP) fields with accuracy, in terms of range and modulation, on the order of one millimeter. Previous studies have also employed Monte Carlo for examination of the dose delivered by primary and secondary particles (Paganetti, 2002, Dowdell et al., 2009, Perez-Andujar et al., 2009, Zacharatou Jarlskog et al., 2008, Zacharatou Jarlskog and Paganetti, 2008b). There is also potential in the use of Monte Carlo simulations for patient specific dose calculation (Paganetti et al., 2008).
The aim of this work was to study the feasibility and potential benefit of incorporating a patient-specific aperture at nozzle exit during delivery of PBS fields. Employing an aperture in PBS should reduce the penumbral width, improving dose conformality and reducing out-of-field doses. We have implemented a model of the PBS treatment head at the Francis H Burr Proton Therapy Center, Massachusetts General Hospital (MGH) using the Geant4 Monte Carlo toolkit. The model was used to simulate the doses in PBS PT with and without a patient-specific aperture. The results of these simulations were compared to simulations of the DS treatment head at MGH.
2. Method
2.1. Monte Carlo modeling of a PBS nozzle
2.1.1. Nozzle Geometry
The components of the PBS nozzle jointly developed by MGH and IBA (Ion Beam Applications, Louvain La Neuve, Belgium) were modeled in the Geant4 code (version 4.9.0.p01)). The geometry as implemented in the Monte Carlo code is shown in figure 1.
Figure 1.
The pencil beam scanning treatment head implemented in the Monte Carlo code, showing the incident beam direction, scanning magnets, ionization chambers (IC) and the snout.
Protons are generated in the simulations at the entrance of the treatment head. Upon entering the treatment head, the beam passes through the first and second scanning magnets, which are used to scan the proton pencil beam horizontally and vertically respectively. The Monte Carlo code reads in the prescribed lateral spot positions and proton energy at the treatment head exit via an input file which is directly generated by the treatment planning system (TPS). These parameters are translated into magnetic field settings using an automated script which converts the prescribed lateral position to the required field strength in both scanning magnets based on the proton mass, the proton energy of the current layer and the required deviation from the central axis. Using the file generated by the TPS ensures that the beam moves throughout a single two-dimensional layer with the same scanning pattern in the simulation and the clinical delivery. The three-dimensional dose distribution is delivered in a series of two-dimensional layers of constant energy (and hence range). The layers are delivered sequentially, commencing with the distal layer (highest proton energy) and concluding with the most proximal (lowest proton energy) layer. The specification of the spot positions and the beam current delivered in the input file also determines whether spot scanning or continuous scanning is delivered.
The magnetic fields generated by the scanning magnets are modeled as uniform fields inside the magnet volume and the magnetic field strength set to zero external to the magnet volume. The field centers are defined based on drawings provided by the manufacturer (Ion Beam Applications) and the field lengths are defined by the effective lengths of the two scanning magnets. This same methodology was also used for the specification of the magnetic fields in the study of Peterson et al (2009).
As protons, or secondary particles, traverse the magnetic fields, their maximum step size in the Monte Carlo was restricted to 2mm. Monte Carlo simulations typically model particle trajectories as a series of straight lines and restricting the maximum step ensures more accurate modeling of the curved trajectory of charged particles through the magnetic fields. Elsewhere in the treatment head, the maximum step size was set to 100mm as high accuracy modeling of the trajectories was not important in these areas of the treatment head and reducing the maximum step size would increase simulation time. All particle interactions with different elements of the treatment head were still modeled, as the particles trajectory and information (energy, momentum etc) are recalculated by default in Geant4 when crossing volume boundaries. It is thus unlikely that a particle travels up to the maximum step size without changing its direction or energy.
After passing through the scanning magnets, the beam then passes through the ionization chambers. It is imperative to include the ionization chambers in the model of a PBS nozzle as proton interactions with the chambers can result in wide-angle scatter increasing the out-of-field dose. The ionization chambers used in the PBS nozzle are the same as those in the DS treatment head.
Finally, the beam passes through the snout, which can be used to hold a patient-specific aperture. Each of the different snout sizes available in the clinic which were previously modeled in the Monte Carlo for the DS system (Paganetti et al., 2004) can also be included in the PBS simulation code. In the design of the treatment head it was anticipated that there may be clinical PBS cases in which patient-specific apertures or compensators are required (Kooy et al., 2010). Examples of such cases would include treatments of tumors located in close proximity to critical structures (e.g. spinal column) where an aperture or range compensator could be used to sharpen the lateral or distal penumbrae respectively. The Monte Carlo code also has the capability of including these patient-specific devices.
2.1.2. Definition of the proton phase space at treatment head entrance
It has been shown previously that the phase space at nozzle entrance can be modeled using four parameters (energy, energy spread, geometrical sigma, and angular spread) and that these parameters can be treated independently for DS delivery simulations (Paganetti et al., 2004). It was also shown that the beam delivery was insensitive to small variations in these parameters. However, PBS delivery can be expected to be more sensitive due to the lack of a scattering system. In this work, Twiss parameters are used in the Monte Carlo to govern the emission of protons at nozzle entrance. A general explanation of Twiss parameters can be found elsewhere (e.g. Edwards and Syphers, 1993). The Twiss parameters (α, β, γ) are calculated from a solution to the Hill equation (Hill, 1886).
| (1) |
where x is displacement, s is time and kx is a periodic function. For such an equation, there exists a general solution of the form
| (2) |
where ε and φ are arbitrary constants and β(s) is a periodic function defined by the focusing properties of the system. Equation 2 describes the particle position. Taking the derivative of equation 2 with respect to s yields
| (3) |
where
| (4) |
The final form of equation 3 describes the angular deviation of the particle. The Twiss parameters are used to govern the position and angular deviation of the protons generated in the Monte Carlo simulations. The emittance is given by
| (5) |
and thus it is related to the area covered by the x, x′ phase space ellipse shown in figure 2. Gaussian distributions ( ) are assumed for the position and angular deviation.
Figure 2.
A two-dimensional ellipse of area πε based on the Twiss parameters α, β and γ.
The Twiss parameters incorporated into the Monte Carlo code are functions of the proton range in water at nozzle entrance, R (g/cm2), and vary quadratically in a drift space. The variation in Twiss parameters with range arises from the increased lateral scattering as the proton energy (and momentum) is decreased. Additionally, lower energy beams have a wider momentum distribution, due to increased range straggling.
Initial values of the Twiss parameters were obtained from a transport calculation on the clinical beamline (Rohrer, 2007, Brown et al., 1980). Manual optimization of width of the Gaussian distributions of position and angular distribution was performed such that the spot size obtained at isocenter in air in Geant4 simulations of different proton beam energies matched the results obtained from measurements at the clinical PBS system at MGH using a Wellhofer MatriXX detector (IBA Dosimetry).
The Twiss parameters (α,β,γ) together with the emittance (ε) describe the beam trajectory at the nozzle entrance. The initial energy of the proton is defined by the range required (specified in input file from TPS) and the calculated initial energy spread distribution at nozzle entrance.
2.1.3. Geant4 physics models
The different physics models available in the Geant4 toolkit were compared in a previous study by Zacharatou Jarlskog and Paganetti (Zacharatou Jarlskog and Paganetti, 2008a) with the aim of finding the best models for use in Monte Carlo simulations of PT. The results of this previous study dictated the physics models used in the PBS Monte Carlo code.
To model the electromagnetic interactions, the G4EmStandard (Agostinelli et al., 2003) model was used. This model governs the interactions of photons and all charged particles which have energy greater than 1keV. The Bethe-Bloch equation is used for specifying the energy loss of hadrons of energy greater than 2MeV. Inelastic hadronic interactions were modeled using a binary cascade (G4BinaryCascade) (Folger et al., 2004) whilst the particle energy of is greater than 100MeV. Once the energy of the particle falls below 100MeV, the precompound model (G4PreCompoundModel) is invoked. Elastic interactions are governed by the UHElastic model (Ivanchenko, 2006).
The DS code previously developed by Paganetti et al (Paganetti et al., 2004) has been shown to predict absolute doses in water within an accuracy of 1.5% compared to ionization chamber measurements (Paganetti, 2006). Since we have used the same physics models for the Monte Carlo simulations in this study, one could expect comparable agreement using the PBS code for absolute doses. The comparisons performed in this study only considered relative doses, which may lead to better agreement than 1.5%.
In terms of secondary radiation, extensive validation of the nuclear models used in the Monte Carlo has been previously undertaken through comparisons with Faraday cup measurements (Zacharatou Jarlskog and Paganetti, 2008a). Direct comparison of the Monte Carlo doses with ionization chamber measurements external to the primary field in proton therapy demonstrated the suitability of the chosen physics models for simulation of out-of-field doses in PT (Clasie et al., 2009).
2.2. Calibration and validation of PBS Monte Carlo code
Depth dose curves were measured using a plane-parallel chamber with an entrance window of diameter 84mm (PTW Freiburg GmbH). The depth dose curves were measured in a water tank for proton pencil beams at five different ranges, 8.92g/cm2, 12.64g/cm2, 15.92g/cm2, 21.1g/cm2 and 25.15g/cm2. The proton energy is specified in the Monte Carlo as a Gaussian distribution. The energy spread of the beam at nozzle entrance was determined by minimizing the χ2 of the Gaussian energy distribution such that the best possible agreement was obtained between the Monte Carlo and experimental depth dose curves for different nominal energies over the range of therapeutic energies deliverable at MGH. Combining the specification of the energy distribution at nozzle entrance with the Twiss parameters allows the specification of all properties of the proton beam required for Monte Carlo simulations.
The lateral deviation of the proton beam from the central axis is directly related to the strength of the magnetic field in the scanning magnets. The script used to convert lateral position to scanning magnet field strength in the Monte Carlo code was verified to ensure that the lateral spot position observed in simulations matched the position prescribed by the input file within 1mm at five different ranges, 8.92g/cm2, 12.64g/cm2, 15.92g/cm2, 21.1g/cm2 and 25.15g/cm2.
The simulation of a complex two-dimensional test pattern was compared to measurements using a Beam Imaging System (BIS) (Ion Beam Applications Dosimetry) at isocenter in air. The BIS uses a 30cm × 30cm scintillator and a CCD camera to capture the image. The energy deposition in the Monte Carlo simulation was obtained at isocenter in air using a 30cm × 30cm × 0.2cm volume of water with the front face placed at isocenter and the maximum step size restricted to 0.02mm. The lateral voxel size used in both the Monte Carlo simulation and experimental measurement was 0.73mm × 0.73mm. Monte Carlo simulations and experimental measurement where compared via gamma analysis (Low et al., 1998. The scanning pattern used in this comparison validates all aspects of the Monte Carlo simulations (other than range), by combining position, spot size and dose delivery checks into a single field.
Table 1 shows the different parameters considered in the PBS Monte Carlo code and the method of calibration and/or validation.
Table 1.
Methods of calibration and validation of the different aspects of the PBS Monte Carlo code used in this study.
| Parameter | Configured and validated by |
|---|---|
| Proton range | Depth dose curves in water tank |
| Energy spread at nozzle entrance | Minimizing χ2 of MC results against experimental measurement in water tank |
| Scanning magnet field strength | Measurement of lateral spot positions for different ranges using the BIS Complex 2D irradiation |
| Spot size | Calibration of Twiss parameters (α,β,γ) Complex 2D irradiation |
MC = Monte Carlo, BIS = Beam Imaging System
2.3. Monte Carlo simulations of clinical prostate field
A prostate field was chosen because of the typically large range used in these treatments. The lateral field size is defined in DS as the area contained within the projection of the patient-specific aperture upon the phantom. The DS and PBS fields were both optimized on the patient CT with the same target volumes and match at the 98% dose level. The PBS field had a range (R90, the depth of the 90% dose level on the distal edge of the SOBP) of 22.8g/cm2, a modulation (M90-90, the distance between the 90% dose levels on the proximal and distal edges of the SOBP) of 10.4g/cm2 and a lateral field size of 45.2cm2.
All simulations of the clinical prostate field were performed in two separate parts. In the first step, the primary protons (and secondary particles) were transported through the treatment head (either DS or PBS), resulting in the generation of a phase space file at nozzle exit which contained the energy, position and direction of all particles which exited the treatment head. The properties phase space files were then used to define the initial conditions of the second step which transported the particles from nozzle exit into the phantom. The maximum step size was restricted to 0.2mm for all particles in the phantom. Using the phase space allowed the field to be simulated upon the phantom multiple times whilst requiring calculation of the particle transport through the treatment head only once, thereby making the simulation process more time efficient. Each full simulation (treatment head and phantom) took approximately 5 days to complete. This long simulation time was required to achieve acceptable statistics in the scoring volumes distal to and at large lateral distances from the primary field.
In addition to conventional PBS, the aperture used in the DS simulations was placed at nozzle exit for a series of PBS simulations. The primary fields were incident upon a Lucite phantom of size 90cm × 26cm × 37.76cm in all the simulations for all delivery techniques.
In addition to scoring volumes along the central axis, distances from the lateral field edge of 2.5cm, 5cm, 7.5cm, 10cm, 15cm, 20cm, 30cm, 40cm and 50cm were considered at depths of 4.72cm, 9.44cm, 14.16cm, 18.88cm, 23.6cm, 28.32cm and 33.04cm in Lucite. To increase statistics, larger volumes were used out-of-field where the dose gradient is not as steep. The volume sizes varied based on the lateral distance (x) from the field edge. The sizes used were 3.8 × 3.8 × 1.1 mm3 (x ≤ 5cm), 7.6 × 7.6 × 1.1 mm3 (5cm < x ≤ 20cm) and 15 × 15 × 1.1 mm3 (x > 20cm) (see figure 3). A similar methodology was adopted in the previous work of Clasie et al (2009).
Figure 3.
Diagram of the scoring volume positions simulated. The black rectangles show the position, orientation and relative size of the detector volumes. The size of the scoring volumes used varied based on the distance from the field edge (x) and were 1.1 × 3.8 × 3.8 mm3 (x ≤ 5cm), 1.1 × 7.6 × 7.6 mm3 (5cm < x ≤ 20cm) and 1.1 × 15 × 15 mm3 (x > 20cm). The detectors at the phantom entrance and along the central axis were rotated by 90° so the majority of particles passed through the largest face of the scoring volumes. The colored area shows the section of the phantom irradiated by the primary field and a depth-dose curve demonstrates the modulation width of the SOBP.
The absorbed dose was obtained in each of the scoring volumes and separated based on particle type. This allowed application of particle specific weighting factors for low dose radiations. The absorbed dose due to protons (Dp), neutrons (Dn) and photons (Dγ) was tallied separately. Neutron energy spectra were also collected in 1MeV bins during the Monte Carlo simulations which allowed calculation of the average radiation weighting factor, wR, based on the ICRP definition (ICRP 2003). The average neutron weighting factors were then used to convert the absorbed dose (D) to equivalent dose (H) using equation 6. Photons are given a factor of 1, whilst protons are assigned a factor of 2 to account for secondary particles which deposit dose locally such as δ-electrons and charged nuclear fragments (ICRP, 2003).
| (6) |
3. Results
3.1. Monte Carlo calibration and validation
3.1.1. Depth dose characteristics
Depth dose curves were measured using a plane-parallel chamber with an entrance window of diameter 84mm (PTW Freiburg GmbH) in a water tank for proton pencil beams of range, 8.92g/cm2, 12.64g/cm2, 15.92g/cm2, 21.1g/cm2 and 25.15g/cm2 (see figure 4). The dose was scored in the Monte Carlo using cylindrical voxels of diameter 84mm and thickness 0.2mm to give high depth resolution and to match the lateral dimensions of the plane-parallel chamber. The results shown in figure 4 are the mean of 10 independent simulations which each cycled through their respective phase space files 5 times (total ~34 million particles transported into the phantom in each simulation). The uncertainty in the depth-dose curves was defined as the standard deviation of the 10 simulations and is less than 1% at all depths for all simulations. Emphasis was placed on taking measurements close to the Bragg peak and on the distal edge for range verification and calibration of the initial energy spread at nozzle entrance. The initial energy spread (ΔE) in terms of proton energy (E) was determined by comparing experimental and simulated pristine Bragg curves and is given in equation 7.
Figure 4.
Depth dose curves for (a) 8.92g/cm2, (b) 12.64g/cm2, (c) 15.92g/cm2, (d) 21.1g/cm2 and (e) 25.15g/cm2. The solid line is the Monte Carlo data and the squares represent experimental data points. The uncertainty in the Monte Carlo is <1% at all points.
| (7) |
The results of the depth dose curves demonstrate good agreement between the measurement and simulation data.
3.1.2. Scanning magnet field strength
The magnetic field calibration was performed for beams of range 8.92g/cm2, 12.64g/cm2, 15.92g/cm2, 21.1g/cm2 and 25.15g/cm2. These ranges correspond to nominal energies of 95.69MeV, 112.53MeV, 138.08MeV, 156.67MeV and 174.74MeV at nozzle entrance for the MGH PBS system, respectively. Five distinct spots were irradiated for each of the energies at different lateral positions (figure 5). The results shown in figure 5 are averages of 10 independent simulations, each containing ~34 million primary protons and are a superposition of the 5 spots for the 5 different energies considered (i.e. total of 25 spots). The lateral spot positions in the Monte Carlo matched those measured using the BIS within 1mm for each considered energy, demonstrating that the conversion of lateral position to magnetic field strength varies correctly with proton energy (and hence range).
Figure 5.
Calibration of magnetic fields to control lateral position of the proton beam in the Monte Carlo simulations. The units on the color scale are relative to the maximum observed value. The data in the figure contains the 5 considered ranges (8.92g/cm2, 12.64g/cm2, 15.92g/cm2, 21.1g/cm2 and 25.15g/cm2).
3.1.3. Complex two-dimensional irradiation
Figure 6 shows the results of the Monte Carlo simulation (a) and experimental delivery (b) of the test pattern.
Figure 6.
Simulated (a) and measured (b) complex 2 dimensional irradiation containing areas of variable dose, continuous scanning and spot scanning.
The Monte Carlo simulation plot is an average of 10 independent simulations, each containing ~34 million primary protons. The uncertainty in the Monte Carlo data was less than 1% at all points considered. The dose was normalized to the maximum dose observed in both the simulated and experimental data. Relative doses were used rather than absolute as the BIS is not capable of measuring absolute dose. The simulated and measured results were compared via gamma analysis (Low et al., 1998), with 100% of the points passing the 2mm/2% criteria.
3.2. The impact of apertures in beam scanning on the example of a prostate treatment field
Figure 7 shows the absorbed doses and equivalent doses at different lateral distances from the field edge at depths of 4.72cm, 18.88cm and 28.32cm. At a depth of 4.72cm in Lucite, the absorbed dose (see figure 7a) at 2.5cm out-of-field is approximately 3 times higher for PBS than DS. Using an aperture in PBS reduces the absorbed dose by over an order of magnitude to levels lower than those achievable in DS. PBS improves when considering equivalent dose (figure 7b), due to the lower neutron component of the total dose (4.6%) compared to DS (21.8%) and PBS with an aperture (27.7%) at 2.5cm from the field edge. At the same position, the photon component is higher in PBS with an aperture (27.1%) than in DS (12.5%). 3.1% of the absorbed dose is attributed to photons in PBS with no aperture, meaning that at this depth and 2.5cm from the field edge 92.3% of the absorbed dose is due to scattered protons. This highlights the potential gains in reducing the penumbral width and hence the proton dose lateral to the field in PBS. The benefit of an aperture in PBS is diminished for lateral distances greater than 7.5cm. At 10cm from the field edge and a depth of 4.72cm, the neutron component of the total absorbed dose is 32.1% and 30.0% for PBS with and without an aperture respectively, compared to 63.7% for DS.
Figure 7.
Simulated absorbed doses (left column) and equivalent doses (right column) at different lateral distances from the field edge at depths of 4.72cm (a and b), 18.88cm (c and d) and 28.32cm (e and f). The doses are relative to the absorbed dose delivered in the SOBP. The data shown is for the double scattering (squares), pencil beam scanning (circles) and pencil beam scanning with a patient-specific aperture (triangles). The error bars represent two standard deviations.
At 18.88cm depth (figure 7c), the absorbed dose close to the field edge is again clearly higher in PBS than the other considered delivery techniques. This depth lies within the SOBP. Figures 7c and 7d show how the aperture in PBS sharpens the lateral penumbra and reduces the absorbed dose and equivalent dose close to the field edge. At 2.5cm from the field edge, the absorbed dose in PBS reduced by more than an order of magnitude when the aperture is used. The absorbed dose from DS is higher than PBS at all lateral distances greater than 10cm from the field edge. The equivalent dose curves (figure 7d) agree within the uncertainty limits for the PBS and PBS with an aperture data for lateral distances greater than 20cm. The higher equivalent dose values observed for the DS data highlights the contribution of neutrons generated in the treatment head for this delivery technique. At all lateral distances from the field edge greater than 5cm considered at 18.88cm depth, neutrons generated in the treatment head contribute to at least 40% of the total absorbed dose in DS. The maximum contribution of neutrons generated in the treatment head in PBS with an aperture is 5.5% at 50cm from the lateral field edge.
The contribution of primary protons to the total absorbed dose and equivalent dose distal to the SOBP is zero due to their finite range. Thus, the absorbed dose and equivalent dose values obtained distal to the SOBP (see figures 7e and 7f) are entirely due to secondary particles. The higher doses observed distal to the SOBP in DS are due to the higher number of secondary particles, particularly neutrons, generated in the treatment head compared to the PBS techniques. As the depth in the phantom increases, the relative contribution from internally generated secondary particles to the total dose increases. The increased neutron fluence from the treatment head in DS yields a higher neutron absorbed dose and equivalent dose compared to both of the PBS techniques considered. The increased number of secondary neutrons generated in the DS treatment head leads to an increased production of secondary particles within the phantom, the effect of which can still be observed distal to the SOBP. The effect of the patient-specific aperture in PBS is less prominent distal to the SOBP than at the shallower depths. There is a slight reduction in the absorbed and equivalent doses distal to the SOBP when using a patient-specific aperture in PBS. The reduction in the penumbral width gained using the aperture reduces the proton fluence and dose lateral to the primary field. This reduction in proton fluence leads to a decrease in secondary particle production, the effect of which can be seen in the lower out-of-field doses throughout the phantom compared to PBS with no aperture.
4. Discussion and Conclusion
Placing a patient-specific aperture at nozzle exit reduces the out-of-field doses from PBS. Proton interactions occurring in the brass of the aperture lead to a higher neutron fluence compared to conventional PBS with no aperture. The neutron component of the total dose out-of-field increases when using an aperture in PBS, however the overall doses are still reduced. The reduction in the dose from primary protons, due to the removal of large angle scatter by the aperture leads to a reduction in the total absorbed dose and equivalent dose when an aperture is placed at nozzle exit. The number of proton interactions in the aperture is much lower in PBS than in DS. In DS, a large proportion of the primary beam interacts with the aperture, leading to a high neutron and secondary particle fluence. In PBS, a comparatively small amount of interactions occur in the aperture, as the majority of the primary protons pass through the aperture without undergoing an interaction. The aperture only interacts with particles which have been scattered through large angles.
One of the reasons for moving to PBS in preference to DS is the removal of the dependency upon patient-specific hardware, which adds to the cost of operating a clinical proton facility. However, one of the issues with scanning is the wider penumbra when the pencil beam width is large and/or the proton energy is small, which is demonstrated in the simulation results presented here. Placing a patient-specific aperture at nozzle exit in PBS reduces the penumbral width and reduces the out-of-field dose. There are other possibilities for improving the beam penumbra such as improving the accelerator design or using quadrupole magnets to focus the beam and give a smaller spot size. However, these methods will not prevent particles which have undergone wide-angle scattering from reaching the patient.
The variation in hardware and beamline setups between proton facilities implies that the amount of benefit gained from using a patient-specific aperture in scanning will vary. The inherently sharper lateral penumbra obtained when using a smaller spot size implies that proton facilities capable of producing such spot sizes will benefit less from using an aperture. The use of a patient-specific aperture may be required to decrease the penumbral width for certain clinical cases, but the other advantages of PBS compared to DS will still be largely maintained. The results of the simulations in this work show that using an aperture can potentially reduce the absorbed dose and equivalent dose lateral to the primary field in PBS by an order of magnitude. Further simulations are required to show the potential benefit of patient-specific apertures in PBS for other treatment sites and field configurations.
Acknowledgments
One of the authors (SD) acknowledges financial support from Australian Rotary Health and the Rotary Clubs of Riverside. One of the authors (PM) acknowledges support from the Cancer Institute of NSW Clinical Leaders Program. One of the authors (HP) was in part funded by NIH/NCI R01 CA140735.
References
- Agostinelli S, et al. Geant4—a simulation toolkit. Nuclear Inst and Methods in Physics Research, A. 2003;506:250–303. [Google Scholar]
- Brown KL, Carey DC, Iselin C, Rothacker F. Transport, a Computer Program for Designing Charged Particle Beam Transport Systems. Yellow Reports CERN 73–16 (1973) & CERN 80–04(1980) 1980 [Google Scholar]
- Clasie B, Wroe A, Kooy H, Depauw N, Flanz J, Paganetti H, Rosenfeld A. Assessment of out-of-field absorbed dose and equivalent dose in proton fields. Med Phys. 2009;37:311–21. doi: 10.1118/1.3271390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dowdell S, Clasie B, Wroe A, Guatelli S, Metcalfe P, Schulte R, Rosenfeld A. Tissue equivalency of phantom materials for neutron dosimetry in proton therapy. Med Phys. 2009;36:5412–9. doi: 10.1118/1.3250857. [DOI] [PubMed] [Google Scholar]
- Edwards DA, Syphers MJ. An Introduction to the Physics of High Energy Accelerators. Wiley and Sons; 1993. [Google Scholar]
- Folger G, Ivanchenko VN, Wellisch JP. The Binary Cascade. The European Physical Journal A-Hadrons and Nuclei. 2004;21:407–17. [Google Scholar]
- Hill GW. On the Part of the Motion of Lunar Perigee Which is a Function of the Mean Motions of the Sun and Moon. Acta Math. 1886;8:1–36. [Google Scholar]
- ICRP. Relative Biological Effectiveness (RBE), Quality Factor (Q), Radiation Weighting Factor (wR) 2003. [DOI] [PubMed] [Google Scholar]
- Ivanchenko VN. Combined cross-sections and elastic scattering. 11th Geant4 Collaboration Workshop and Users Conf; Lisbon, Portugal. 2006. [Google Scholar]
- Kooy HM, et al. A case study in proton pencil-beam scanning delivery. Int J Radiat Oncol Biol Phys. 2010;76:624–30. doi: 10.1016/j.ijrobp.2009.06.065. [DOI] [PubMed] [Google Scholar]
- Lomax AJ, Pedroni E, Rutz H, Goitein G. The clinical potential of intensity modulated proton therapy. Z Med Phys. 2004;14:147–52. doi: 10.1078/0939-3889-00217. [DOI] [PubMed] [Google Scholar]
- Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25:656–61. doi: 10.1118/1.598248. [DOI] [PubMed] [Google Scholar]
- Paganetti H. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles. Phys Med Biol. 2002;47:747–64. doi: 10.1088/0031-9155/47/5/305. [DOI] [PubMed] [Google Scholar]
- Paganetti H. Monte Carlo calculations for absolute dosimetry to determine machine outputs for proton therapy fields. Phys Med Biol. 2006;51:2801–12. doi: 10.1088/0031-9155/51/11/008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paganetti H, Jiang H, Lee SY, Kooy HM. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. Med Phys. 2004;31:2107–18. doi: 10.1118/1.1762792. [DOI] [PubMed] [Google Scholar]
- Paganetti H, Jiang H, Parodi K, Slopsema R, Engelsman M. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy. Phys Med Biol. 2008;53:4825–53. doi: 10.1088/0031-9155/53/17/023. [DOI] [PubMed] [Google Scholar]
- Perez-Andujar A, Newhauser WD, Deluca PM. Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system. Phys Med Biol. 2009;54:993–1008. doi: 10.1088/0031-9155/54/4/012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peterson SW, Polf J, Bues M, Ciangaru G, Archambault L, Beddar S, Smith A. Experimental validation of a Monte Carlo proton therapy nozzle model incorporating magnetically steered protons. Phys Med Biol. 2009;54:3217–29. doi: 10.1088/0031-9155/54/10/017. [DOI] [PubMed] [Google Scholar]
- Rohrer U. PSI Graphic Transport Framework based on a CERN-SLAC-FERMILAB version by K L Brown et al. 2007. [Google Scholar]
- Schneider U, Agosteo S, Pedroni E, Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys. 2002;53:244–51. doi: 10.1016/s0360-3016(01)02826-7. [DOI] [PubMed] [Google Scholar]
- Zacharatou Jarlskog C, Lee C, Bolch WE, Xu XG, Paganetti H. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms. Phys Med Biol. 2008;53:693–717. doi: 10.1088/0031-9155/53/3/012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zacharatou Jarlskog C, Paganetti H. Physics Settings for Using the Geant4 Toolkit in Proton Therapy. IEEE Transactions on Nuclear Science. 2008a;55:1018–25. [Google Scholar]
- Zacharatou Jarlskog C, Paganetti H. Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy. Phys Med Biol. 2008b;53:4523–32. doi: 10.1088/0031-9155/53/17/004. [DOI] [PubMed] [Google Scholar]







